Book section icon

Book section

Primary prevention of dementia

Abstract:

Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are being developed and some are in early clinical trials. Primary prevention, rather than treatment of the established disease, must be of equal, if not greater, importance. Common sense suggests that at...

Expand abstract

Actions


Access Document


Publisher copy:
10.1383/psyt.3.12.35.56787

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience
Role:
Author
Volume:
3
Pages:
35-36
Publication date:
2004-12-01
DOI:
URN:
uuid:51b567db-27b1-4817-a7f7-1379357a19c6
Source identifiers:
72434
Local pid:
pubs:72434

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP